CRL
Price
$185.77
Change
+$3.62 (+1.99%)
Updated
Dec 20, 04:59 PM (EDT)
52 days until earnings call
QIPT
Price
$2.49
Change
+$0.08 (+3.32%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
Ad is loading...

CRL vs QIPT

Header iconCRL vs QIPT Comparison
Open Charts CRL vs QIPTBanner chart's image
Charles River Laboratories International
Price$185.77
Change+$3.62 (+1.99%)
Volume$5.04K
CapitalizationN/A
Quipt Home Medical
Price$2.49
Change+$0.08 (+3.32%)
Volume$9.44K
CapitalizationN/A
CRL vs QIPT Comparison Chart
Loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QIPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRL vs. QIPT commentary
Dec 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRL is a Hold and QIPT is a Hold.

COMPARISON
Comparison
Dec 22, 2024
Stock price -- (CRL: $185.77 vs. QIPT: $2.49)
Brand notoriety: CRL and QIPT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CRL: 159% vs. QIPT: 296%
Market capitalization -- CRL: $13.96B vs. QIPT: $183.44M
CRL [@Medical Specialties] is valued at $13.96B. QIPT’s [@Medical Specialties] market capitalization is $183.44M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRL’s FA Score shows that 0 FA rating(s) are green whileQIPT’s FA Score has 1 green FA rating(s).

  • CRL’s FA Score: 0 green, 5 red.
  • QIPT’s FA Score: 1 green, 4 red.
According to our system of comparison, QIPT is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRL’s TA Score shows that 3 TA indicator(s) are bullish while QIPT’s TA Score has 4 bullish TA indicator(s).

  • CRL’s TA Score: 3 bullish, 6 bearish.
  • QIPT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, QIPT is a better buy in the short-term than CRL.

Price Growth

CRL (@Medical Specialties) experienced а -2.46% price change this week, while QIPT (@Medical Specialties) price change was -17.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

CRL is expected to report earnings on Feb 12, 2025.

QIPT is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($14B) has a higher market cap than QIPT($183M). QIPT has higher P/E ratio than CRL: QIPT (476.19) vs CRL (29.15). CRL YTD gains are higher at: -21.417 vs. QIPT (-51.081). CRL has higher annual earnings (EBITDA): 1.03B vs. QIPT (49.8M). CRL has more cash in the bank: 277M vs. QIPT (18.3M). QIPT has less debt than CRL: QIPT (95.8M) vs CRL (3.07B). CRL has higher revenues than QIPT: CRL (4.13B) vs QIPT (246M).
CRLQIPTCRL / QIPT
Capitalization14B183M7,650%
EBITDA1.03B49.8M2,072%
Gain YTD-21.417-51.08142%
P/E Ratio29.15476.196%
Revenue4.13B246M1,678%
Total Cash277M18.3M1,514%
Total Debt3.07B95.8M3,200%
FUNDAMENTALS RATINGS
CRL vs QIPT: Fundamental Ratings
CRL
QIPT
OUTLOOK RATING
1..100
7526
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
82100
SMR RATING
1..100
6390
PRICE GROWTH RATING
1..100
6163
P/E GROWTH RATING
1..100
593
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRL's Valuation (77) in the Miscellaneous Commercial Services industry is in the same range as QIPT (94) in the null industry. This means that CRL’s stock grew similarly to QIPT’s over the last 12 months.

CRL's Profit vs Risk Rating (82) in the Miscellaneous Commercial Services industry is in the same range as QIPT (100) in the null industry. This means that CRL’s stock grew similarly to QIPT’s over the last 12 months.

CRL's SMR Rating (63) in the Miscellaneous Commercial Services industry is in the same range as QIPT (90) in the null industry. This means that CRL’s stock grew similarly to QIPT’s over the last 12 months.

CRL's Price Growth Rating (61) in the Miscellaneous Commercial Services industry is in the same range as QIPT (63) in the null industry. This means that CRL’s stock grew similarly to QIPT’s over the last 12 months.

QIPT's P/E Growth Rating (3) in the null industry is somewhat better than the same rating for CRL (59) in the Miscellaneous Commercial Services industry. This means that QIPT’s stock grew somewhat faster than CRL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLQIPT
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
63%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
76%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 14 days ago
72%
Bullish Trend 7 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 5 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
79%
View a ticker or compare two or three
Ad is loading...
CRL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QIPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
QRLVX30.980.42
+1.37%
Federated Hermes MDT Large Cap Value R
KMDVX31.450.35
+1.13%
Keeley Mid Cap Dividend Value A
MLGLX9.140.10
+1.11%
Gabelli Media Mogul A
PWJRX29.06N/A
N/A
PGIM Jennison International Opps R
FERIX49.94N/A
N/A
Fidelity Advisor Emerging Asia I

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
+1.99%
IQV - CRL
73%
Closely correlated
+3.00%
CTKB - CRL
60%
Loosely correlated
+2.10%
RGEN - CRL
56%
Loosely correlated
-1.42%
MEDP - CRL
56%
Loosely correlated
+0.64%
AZTA - CRL
55%
Loosely correlated
+1.88%
More

QIPT and

Correlation & Price change

A.I.dvisor tells us that QIPT and ENZ have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QIPT and ENZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QIPT
1D Price
Change %
QIPT100%
+3.32%
ENZ - QIPT
29%
Poorly correlated
+7.05%
VREX - QIPT
28%
Poorly correlated
-1.53%
KIDS - QIPT
28%
Poorly correlated
-0.93%
NEOG - QIPT
26%
Poorly correlated
+0.17%
CRL - QIPT
26%
Poorly correlated
+1.99%
More